A health policy think-tank had dire warnings earlier this month about the future of the U.S. health-care system.
Unless reform becomes a reality, most Americans can expect to pay health insurance premiums that will double by 2016, said the Public Interest Research Group.
“As costs rise, one out of three American’s health-care dollars are going to waste and inefficiency,” said report co-author Larry C. McNeely, who noted a major problem was inflated drug prices.
The report said U.S. pharmaceutical manufacturers spend more than US$11.5 billion annually on marketing prescription drugs.